Psychiatrists looking for a new treatment to give patients with major depression and suicidal tendencies may soon be able to administer ketamine inside of their offices.
If ketamine is approved by the Federal Drug Administration as a breakthrough therapy, it will be the first new treatment for a major depressive disorder in about 50 years, CNN reports. On Tuesday, Janssen Pharmaceutical announced it is working on two clinical trials with ketamine — one for treatment-resistant depression and one for depression with suicidal thoughts, and will present the data to the FDA in 2018. Ketamine is also known as the street drug Special K, which gives users the feeling of being out of their body. It was used in the 1960s as an analgesic and sedative and is still on the World Health Organization's Essential Medicine List, but because of its hallucinogenic side effects, it's mostly used today as a veterinary anesthetic.
Depression causes damage to nerves and their transmission pathways, and research leads scientists to believe ketamine remodels those nerves, triggering neuroplastic processes that make new connections among brain cells, Dr. Dan Iosifescu of the Icahn School of Medicine at Mount Sinai in New York City told CNN. "What's unique about ketamine is, this happens in hours or days, while with other depression medications, this happens in weeks to months," he said. Doctors have some concern that using ketamine for depression could reverse a person's tolerance to opioids or lead to substance abuse, and Janssen said its formulation would only be administered by a doctor in their office.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Home Depots are the new epicenters of ICE raidsIn the Spotlight The chain has not provided many comments on the ongoing raids
-
Why does Trump keep interfering in the NYC mayoral race?Today's Big Question The president has seemingly taken an outsized interest in his hometown elections, but are his efforts to block Zohran Mamdani about political expediency or something deeper?
-
The pros and cons of banning cellphones in classroomsPros and cons The devices could be major distractions
-
Russia slams Kyiv, hits government buildingSpeed Read This was Moscow's largest aerial assault since launching its full-scale invasion in 2022
-
China's Xi hosts Modi, Putin, Kim in challenge to USSpeed Read Chinese President Xi Jinping hosted Indian Prime Minister Narendra Modi, Russian President Vladimir Putin and other Asian leaders at an SCO summit
-
Russian strike on Kyiv kills 23, hits EU officesSpeed Read The strike was the second-largest since Russia invaded in 2022
-
UN votes to end Lebanon peacekeeping missionSpeed Read The Trump administration considers the UN's Interim Force in Lebanon (UNIFIL) to be a 'waste of money'
-
Israeli double strike on Gaza hospital kills 20Speed Read The dead include five journalists who worked for The Associated Press, Reuters and Al Jazeera
-
China is silently expanding its influence in American citiesUnder the Radar New York City and San Francisco, among others, have reportedly been targeted
-
Kyiv marks independence as Russia downplays peaceSpeed Read President Vladimir Putin has no plans to meet with Zelenskyy for peace talks pushed by President Donald Trump
-
Trump halts Gaza visas as Israelis protest warSpeed Read Laura Loomer voiced her concerns over injured Palestinian kids being brought to the US for treatment and a potential 'Islamic invasion'
